Generali Asset Management’s Stantec STN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$305K Sell
3,116
-10,512
-77% -$848K 0.01% 440
2026
Q1
$1.64M Buy
+13,628
New +$1.28M 0.03% 330
2025
Q4
Sell
-8,058
Closed -$1.21M 515
2025
Q3
$1.21M Sell
8,058
-6,872
-46% -$751K 0.03% 386
2025
Q2
$2.21M Buy
+14,930
New +$1.44M 0.05% 284

Other funds holding STN

Generali Asset Management's STN Position: Q2 2026 in Review

Generali Asset Management reduced its Stantec (STN) stake by 77% in Q2 2026, selling an estimated $848K and leaving 3,116 shares worth $305K. The position accounts for 0.01% of the portfolio, ranked #440.

Generali Asset Management first reported a position in STN in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.21M in Q2 2025. 289 funds tracked by Wall St. Rank hold STN as of Q2 2026.

  • Generali Asset Management held 3,116 shares of Stantec worth $305K as of Q2 2026.
  • Generali Asset Management sold 10,512 Stantec shares in Q2 2026, an estimated $848K.
  • Stantec made up 0.01% of Generali Asset Management's portfolio in Q2 2026, its #440 holding.
  • Generali Asset Management first reported a position in Stantec in Q2 2025 and has held it in 4 quarters since.
  • Generali Asset Management's Stantec position peaked at $2.21M in Q2 2025.
  • 289 funds tracked by Wall St. Rank held Stantec as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.